Skip to content

Analysis of the Diagnostic Performance of LacryDiag, a New Analyzer of the Ocular Surface in the Dry Eye

Analysis of the Diagnostic Performance of LacryDiag, a New All-in-one Non-contact Analyzer of the Ocular Surface in the Dry Eye. Study LACRYMOSA

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04093037
Acronym
LACRYMOSA
Enrollment
80
Registered
2019-09-17
Start date
2019-11-14
Completion date
2020-08-27
Last updated
2020-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry Eye

Keywords

Dry eye, LacryDiag, Fluorescein, Break-Up Time (BUT), Schirmer test, Lacrimal film, Oxford score, Meibomian Gland, Tear Meniscus (TM), Non Invasive Break-Up Time (NIBUT)

Brief summary

LacryDiag is a new Conformity European (CE) marked diagnostic imaging device devoted to the analysis of the ocular surface. It is an all in one device that provides 4 data: non-invasive break-up time (Non-Invasive Break-Up-Time (NIBUT) without fluorescein eye drop); height of the Tear Meniscus (TM); an infrared image of the meibomian glands; a picture of the lacrimal film by interferometry. it's performance will be compare between in diagnosing dry eye syndrome with the standard clinical evaluation, in 80 patients suffering from dry eye diseases and followed at the consultation of the Ophthalmology department of the University Hospital of Saint-Etienne.

Detailed description

The primary purpose of this study is to compare the value of Break-Up-Time (BUT) between Non-Invasive Break-Up-Time (NIBUT) measured by LacryDiag and Standard Break-Up-Time (SBUT) measured by usual practice.

Interventions

DIAGNOSTIC_TESTTime #1: Non Invasive Break-Up Time (NIBUT)

A LacryDiag examination without dye will be realized. All measurements are made without contact. It's calculates the Non Invasive Break-Up Time (NIBUT), Tear Meniscus (TM) height (in millimeters) and number of Meibomian Gland. These are different pictures taken with LacryDiag and analyzed.

DIAGNOSTIC_TESTTime #2: MicroInstillation Break-Up Time (MIBUT) + Oxford score

The MicroInstillation of fluorescein Break-Up Time (MIBUT) will be calculated by manual MIBUT and LacryDiag MIBUT. The Oxford score will be calculated. It's used to clinically determine the severity of dry eyes with minimum score at 0 (none) and maximum score at 5 (very severity).

DIAGNOSTIC_TESTTime #3: Standard Break-Up Time (SBUT)

The Standard Break-Up Time (SBUT) with fluorescein macroinstillation will be calculated by manual SBUT and LacryDiag SBUT.

DIAGNOSTIC_TESTTime #4: Schirmer test

The Schirmer test will be performed. It consists of applying the end of a small strip of blotting paper behind the lower eyelid and examining the strip after 5 minutes.

DIAGNOSTIC_TESTSatisfaction questionnaire to the patient

A satisfaction questionnaire to the patient will be completed at the end of the participation at the study.

Sponsors

Centre Hospitalier Universitaire de Saint Etienne
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

80 patients divided into 4 subgroups according to the value of manual Standard Break-Up-Time (SBUT): * 0-5 seconds (very dry) * 5-10 seconds (sec) * 10-15 seconds (moderately dry) * 15-20 seconds (normal)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Affiliates or beneficiaries of social security scheme * With Dry eye of any cause, diagnosed with conventional means * Signed informed consent

Exclusion criteria

* Major blepharospasm * Serious illness preventing participation according to investigator * Allergy to fluorescein * Pregnant or / and breastfeeding women * Under guardianship, curatorship or safeguard of justice * Unable to express their consent * Person in emergency situation

Design outcomes

Primary

MeasureTime frameDescription
Break-Up-Time (BUT)Day: 1Comparison of Break-Up-Time (BUT) measured by 2 methods : LacryDiag Non Invasive Break-Up Time (NIBUT) and manual Standard Break-Up Time (SBUT). Measured in seconds by time#1: Non Invasive Break-Up Time (NIBUT) and time#3: Standard Break-Up Time (SBUT).

Secondary

MeasureTime frameDescription
Standard Break-Up Time (SBUT)Day: 1Comparison of Standard Break-Up Time (SBUT) between LacryDiag SBUT results and manual SBUT results. Measured in seconds. Measured by time#3: Standard Break-Up Time (SBUT).
MicroInstillation Break-Up Time (MIBUT)Day: 1Comparison of MicroInstillation Break-Up Time (MIBUT) between LacryDiag MIBUT results and manual MIBUT results. Measured in seconds by time#1: Non Invasive Break-Up Time (NIBUT) and time#2: MicroInstillation Break-Up Time (MIBUT).
Tear Meniscus (TM) height and Schirmer testDay: 1Correlation between Tear Meniscus (TM) height (in millimeters) and Schirmer test (in millimeters). Measured by time#1: Non Invasive Break-Up Time (NIBUT) and time#4: Schirmer test.
Percentage loss of Meibomian Gland.Day: 1Measured by time#1: Non Invasive Break-Up Time (NIBUT).
Thickness (in nanometer) and regularity of lacrimal film (type)Day: 1Correlation between measure thickness (in nanometer) and regularity of lacrimal film (type). Measured by time#1: Non Invasive Break-Up Time (NIBUT).

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026